The antitumor activities of anti-CD47 antibodies require Fc-FcγR interactions
Author:
Funder
National Institutes of Health
National Cancer Institute
National Center for Advancing Translational Sciences
Memorial Sloan-Kettering Cancer Center
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference77 articles.
1. Cancer immunotherapy using checkpoint blockade;Ribas;Science,2018
2. The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors;Willingham;Proc. Natl. Acad. Sci. USA,2012
3. Signal-regulatory protein is selectively expressed by myeloid and neuronal cells;Adams;J. Immunol.,1998
4. Anti-CD47 antibody synergizes with rituximab to promote phagocytosis and eradicate non-Hodgkin lymphoma;Chao;Cell,2010
5. CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells;Majeti;Cell,2009
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Unveiling the role of RNA methylation in glioma: Mechanisms, prognostic biomarkers, and therapeutic targets;Cellular Signalling;2024-12
2. Bi-specific antibody engagers for cancer immunotherapy;2024-08-01
3. CD47-mediated immune evasion in early-stage lung cancer progression;Biochemical and Biophysical Research Communications;2024-08
4. Deciphering Regulatory T-Cell Dynamics in Cancer Immunotherapy: Mechanisms, Implications, and Therapeutic Innovations;ACS Pharmacology & Translational Science;2024-07-03
5. Development of pharmacological immunoregulatory anti-cancer therapeutics: current mechanistic studies and clinical opportunities;Signal Transduction and Targeted Therapy;2024-05-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3